Skip to content

Other product segments

Health
83%+0.2%
Financial
51.6%-23.2%
Specialty
45%-31.0%
Casualty
34%+0.6%
Property
33.5%+0.9%

Similar metrics at other companies

Arch Capital Group logo
ACGLMulti-line and other specialty — Year Two
29%-0.2pp
Skyward Specialty Insurance Group, Inc. logo
SKWDShort-tail/Monoline Specialty Lines — Year 2
38.1%+0.4pp
Skyward Specialty Insurance Group, Inc. logo
SKWDMulti-line Solutions — Year 2
21.6%-0.4pp
Axis Capital Holders logo
AXSInsurance — Year 2
38.8%
Arch Capital Group logo
ACGLMulti-line and other specialty — Year One
31.2%-1.6pp
Skyward Specialty Insurance Group, Inc. logo
SKWDMulti-line Solutions — Year 1
23.9%-2.1pp

Other financials

Income statement

See full
Revenue$189.7M-11.1%
Net income$35.8M+20.7%
EPS (diluted)$1.05+22.1%

Balance sheet

See full
Cash & equivalents$610.2M-5.1%
Total debt$4.7M-92.1%
Total equity$741.2M+11.2%
Total assets$2.3B+5.4%

Cash flow

See full
Operating cash flow$37.2M+259%

Valuation

See full
Market cap$533.32M+7.2%
Enterprise value-$72.18M-15.4%
P/E6.6×
P/S0.8×+0.1×

Profitability

See full
Net margin11.5%
FCF margin-46.7%

Returns & leverage

See full
Return on equity11.5%
Debt / equity-0.1×

Where this comes from

Reported directly by Greenlight Capital RE, Ltd. in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo.

The official record: Greenlight Capital RE, Ltd.’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Greenlight Capital RE, Ltd.'s multiline — year 2.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Greenlight Capital RE, Ltd.'s multiline — year 2?
Greenlight Capital RE, Ltd. (GLRE) reported multiline — year 2 of 73% in Q4 2025.
How has Greenlight Capital RE, Ltd.'s multiline — year 2 changed year-over-year?
Greenlight Capital RE, Ltd.'s multiline — year 2 decreased by 1.9% year-over-year, from 74.4% to 73%.
What does multiline — year 2 mean?
Represents the claim development or financial performance metrics associated with the second year of the underwriting cycle for the multiline segment. This metric allows for the assessment of how loss estimates for a specific cohort evolve as more claims are reported. It is essential for validating the accuracy of initial actuarial assumptions.